Contract Manufacturing in Biopharma Evolving Beyond COVID-19
The COVID-19 pandemic catalyzed changes to the biopharma manufacturing landscape, with agility, innovation, and resilience becoming necessary prerequisites. And digital transformation, single-use technologies, and strategic partnerships were driving ...
pharmafocus.hashnode.dev3 min read